Herbalife Nutrition Ltd.

Herbalife Nutrition Ltd. (HLF) Market Cap

Herbalife Nutrition Ltd. has a market capitalization of .

No quote data available.

CEO: Stephan Paulo Gratziani

Sector: Consumer Defensive

Industry: Packaged Foods

IPO Date: 2004-12-16

Website: https://www.herbalife.com

Herbalife Nutrition Ltd. (HLF) - Company Information

Market Cap: -|Sector: Consumer Defensive

Company Profile

Herbalife Nutrition Ltd. is a global enterprise dedicated to providing comprehensive nutritional solutions. Its market presence extends across various international regions, including North America, Mexico, Central and South America, Europe, the Middle East, Africa, China, and the broader Asia Pacific area. The company’s extensive product catalog caters to several core wellness categories, encompassing weight management, specialized nutritional supplementation, energy and athletic performance, and external personal care. Specifically, its weight management offerings feature items like meal replacements, protein shakes, powdered drink mixes, weight loss aids, and healthy snacks. For targeted nutrition, Herbalife provides functional beverages alongside dietary and nutritional supplements rich in herbs, vitamins, minerals, and other naturally derived ingredients. The outer nutrition range includes products for facial, body, and hair care, while its energy, sports, and fitness segment includes popular items such as N-R-G tea and various energy drinks. In addition to its product lines, Herbalife furnishes supporting materials, which comprise start-up kits, sales tools, informational literature, and educational resources. The company employs a multi-channel distribution strategy, primarily leveraging independent service providers and sales representatives, alongside its own company-operated retail platforms. Founded in Los Angeles, California, in 1980, the organization was known as Herbalife Ltd. until April 2018, when it officially rebranded to Herbalife Nutrition Ltd.

Analyst Sentiment

67%
Buy

From 4 Active Polls

1Y Forecast: $17.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$17

High Bound

$17

Average

$17

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$17.00
▲ +36.88% Upside
Low Target
$17.00
37% Risk
Median Target
$17.00
37% Mid
High Target
$17.00
37% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HERBALIFE LTD (HLF) — Investment Overview

🧩 Business Model Overview

Herbalife operates in the global nutrition and weight-management category through an independent distributor network rather than a traditional wholesale/retail model. The value chain runs from the company’s manufacturing and sourcing operations to an inventory system sold primarily to independent distributors, who then market and resell products to end customers and earn commissions based on personal sales and downline activity. This structure creates “repeat behavior” at two levels: distributors maintain ongoing product inventory and customer relationships, while end consumers tend to reorder nutrition programs if they view products as part of their routine.

The model is therefore less dependent on mass media demand generation and more dependent on distributor recruitment, retention, and training—each supported by a standardized compensation and brand/education framework.

💰 Revenue Streams & Monetisation Model

Revenue is driven predominantly by product sales, with a portion of monetisation coming through distributor incentives and related programs that align distributor activity with volume. The key margin drivers are:

  • Unit economics and mix: higher-margin categories (for example, meal replacement and targeted nutrition) and favorable product mix can support gross margin.
  • Distributor demand stability: because distributors purchase inventory for resale, revenue visibility depends on distributor re-order cycles and customer replenishment.
  • Cost discipline: marketing, distribution support, and operating overhead linked to network growth influence operating leverage.

Overall, the monetisation profile is “recurring-like” in practice due to repeat consumption, even though accounting revenue is largely tied to shipment/inventory purchase events within the distributor network.

🧠 Competitive Advantages & Market Positioning

Herbalife’s competitive position is anchored in structural distribution and behavioral stickiness rather than proprietary technology.

  • Network effects (indirect): the distributor model creates a self-reinforcing sales capability. A larger active network improves local availability, peer education, and customer acquisition, which in turn can improve distributor productivity.
  • Switching costs (behavioral): customers often build routines around a preferred product set and ordering relationship. Distributors also accumulate time and know-how (training, customer base, community) that is not costless to replicate.
  • Distribution scale and execution: compared with smaller independent nutrition brands, scale supports more consistent market coverage, distributor training infrastructure, and localized go-to-market execution.

Competitive benchmarking:

  • Amway (Alticor): broader consumer product portfolio with a similar multi-level direct selling approach, typically competing on range and household penetration rather than strict focus on weight-management and meal replacement.
  • Nu Skin Enterprises: also relies on direct selling and beauty/wellness categories, competing for distributor mindshare and consumer attention using comparable network-driven recruitment.
  • DSM-Firmenich / Nestlé Health Science (CPG/health nutrition): competes through retail and institutional distribution, with switching costs driven by brand/availability and convenience rather than distributor networks.

Herbalife’s focus is concentrated on targeted nutrition and weight-management use cases, which differentiates its messaging and product mix from diversified direct sellers and from retail/CPG players that compete primarily on shelf presence and packaged brand equity.

🚀 Multi-Year Growth Drivers

  • Structural demand for weight management and everyday nutrition: increasing health awareness and chronic disease risk factors support long-run consumption of meal replacement, supplement, and targeted nutrition offerings.
  • Expansion and deeper penetration in underpenetrated markets: direct selling models can scale distribution coverage in geographies where retail execution is less efficient or where consumer purchasing behavior favors community-based selling.
  • Distributor productivity improvements: training systems, product education, and support tools can translate into higher customer conversion and improved re-order rates, reinforcing revenue durability.
  • Channel evolution: distributors can complement face-to-face sales with digital merchandising and recurring ordering behaviors, improving convenience while maintaining the network’s local credibility.

⚠ Risk Factors to Monitor

  • Regulatory and legal scrutiny of compensation practices: direct selling structures can face investigations regarding consumer protection, earnings claims, and whether incentive schemes are aligned with legitimate product sales.
  • Product/claims and public health standards: adverse regulatory actions related to health-related marketing claims or quality controls can pressure margins and increase compliance costs.
  • Network sustainability risk: distributor retention and the ability to recruit new participants are critical. Network contraction can reduce distributor purchasing and end-consumer ordering.
  • Reputational risk: litigation, regulatory headlines, or credible allegations can affect recruitment and consumer trust, with downstream effects on sales volumes.
  • Competitive pricing and promotional intensity: nutrition and wellness categories attract both direct sellers and retail brands; sustained price pressure can compress gross margin.
  • Operating and supply chain volatility: ingredient sourcing, manufacturing stability, and tariff/currency movements can influence cost structure.

📊 Valuation & Market View

Markets typically value consumer distribution businesses using EV/EBITDA and EV/Revenue frameworks, with emphasis on the durability of growth and the sustainability of margins. The key valuation sensitivities for Herbalife-like models are:

  • Regulatory risk premium: stricter enforcement or unfavorable outcomes tend to drive multiple compression due to expected margin pressure and growth uncertainty.
  • Margin trajectory: product mix and disciplined operating costs determine earnings power in distributor-based models.
  • Volume quality: investors focus on whether revenue is supported by repeat consumer demand versus accelerated distributor stocking.

🔍 Investment Takeaway

Herbalife’s long-term investment case rests on a repeat-consumption product set distributed through a large independent network. The primary moats are network effects and behavioral switching costs, supported by distribution scale and execution. The central debate for investors is not the presence of a distribution engine, but the extent to which regulatory oversight, reputational factors, and network sustainability can be managed without impairing distributor productivity and customer demand.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"HLF reported Q1 2026 results with Revenue of $1.317B and Net Income of $61.9M (EPS: $0.60 on basic; $0.57 diluted). On a YoY basis, Revenue rose from $1.222B in Q1 2025 to $1.317B in Q1 2026 (+7.9% YoY), while Net Income increased from $50.4M to $61.9M (+22.8% YoY). QoQ, Revenue edged up from $1.283B in Q4 2025 (+2.6% QoQ), but Net Income declined from $85.4M in Q4 (+27.5% QoQ decrease). Profitability was mixed: gross margin improved (77.9% vs 75.1% in Q4), but operating income swung to a small loss (-$5.5M; operating margin -0.4%) after a profitable Q4. Cash flow remained solid, with operating cash flow of $113.8M and free cash flow of $102.9M in the quarter. The balance sheet shows resilience on liquidity (cash $451M) but continued capital structure strain (negative stockholders’ equity; equity of about -$434M). Total shareholder returns were strong given price momentum (1y_change +172.8%) and no evidence of dividends; buybacks appear limited in the quarter. Analyst valuation context is broadly constructive with consensus price target around $17.33 vs the $17.02 price."

Revenue Growth

Good

Revenue +7.9% YoY (Q1 2026 vs Q1 2025) and +2.6% QoQ (Q1 vs Q4 2025), indicating steady top-line momentum.

Profitability

Fair

Net margin improved YoY (4.7% vs ~4.1%), but QoQ Net Income fell (-27.5%) and operating income deteriorated to a small operating loss in Q1 2026 (operating margin -0.4% vs +6.0% in Q4).

Cash Flow Quality

Good

Operating cash flow of $113.8M and free cash flow of $102.9M in Q1 2026 support earnings quality despite margin volatility; no dividends and no buybacks reported in this quarter.

Leverage & Balance Sheet

Caution

Liquidity improved (cash $451M), but balance sheet remains stressed with negative stockholders’ equity (~-$434M) and sizable long-term debt (~$155M) plus higher overall liabilities.

Shareholder Returns

Strong

Strong price momentum (1-year change +172.8%) provides major total return; dividend yield is 0% and buyback activity appears minimal in Q1.

Analyst Sentiment & Valuation

Positive

Consensus target ~$17.33 vs current ~$17.02 implies near-term upside is modest; valuation multiples appear sensitive given recent profitability swings.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

HLF delivered a strong Q1 2026 with net sales of $1.3b (+7.8% YoY) and adjusted EBITDA of $176m, both above the top of guidance. India drove results, posting record sales of $275m (+32% YoY) and continued momentum tied to the late-2025 GST reduction (expected tailwind through September). However, profitability still showed margin pressure: adjusted EBITDA margin fell 20 bps YoY to 13.3% despite a large 240 bps two-year improvement, with FX and absorption/sales-mix headwinds offset by pricing. The company also meaningfully improved its balance sheet via a $1.45b refinancing in April, targeting ~$45m annualized cash interest savings and setting a net leverage goal below 2.0x by year-end. Outlook remains constructive on constant-currency net sales and narrowed EBITDA ranges, but China and North America softness plus India GST-related incremental cost (~$20m–$25m; 40–50 bps) are key watch items.

AI IconGrowth Catalysts

  • India record quarterly net sales for the second consecutive quarter ($275m, +32% YoY) supported by prior late-Sep 2025 GST rate reduction
  • Distributor training and engagement momentum in India following the GST change; management expects GST tailwind through September 2026
  • Preparations for next-generation personalized supplements: Vionic integration into Protocol and rollout beginning June 2026 in 11 EMEA countries, followed by the U.S. in July

Business Development

  • Acquisition completed (April; announced March 26) of substantially all assets of Vionic core personalized nutrition business
  • Planned Vionic personalized nutritional supplements rollout: June 2026 in 11 European countries; U.S. follow in July; additional markets later in 2026
  • Protocol beta expansion to select 10 EMEA markets (from late in 2025), with an enhanced next release planned for North America Extravaganza in July

AI IconFinancial Highlights

  • Net sales: $1.3b (+7.8% YoY; +5.4% constant currency), exceeding high end of guidance (3%–7% range)
  • Adjusted EBITDA: $176m, above high end of guidance ($155m–$175m)
  • Adjusted EBITDA margin: 13.3%, down 20 bps YoY, but up 240 bps on a two-year stacked basis (including ~70 bps FX headwinds)
  • Gross margin: 77.9%, down 40 bps YoY; drivers included ~50 bps input cost inflation (lower absorption), ~30 bps unfavorable sales mix, ~20 bps other unfavorable costs, and ~50 bps FX headwinds, offset by ~70 bps pricing benefits and ~40 bps lower inventory write-downs
  • Adjusted diluted EPS: $0.64, including ~ $0.03 FX headwind; adjusted effective tax rate 27.3% vs 21.8% in 2025, ~ $0.04 unfavorable EPS impact
  • Full-year 2026 adjusted effective tax rate expected ~30%

AI IconCapital Funding

  • April refinancing completed: $1.45b senior secured refinancing including $800m 7.75% notes due May 2033, $225m Term Loan A, and $425m revolving credit facility
  • Annualized cash interest savings: approximately $45m (coupon/spread reductions: notes coupon down 450 bps; revolver spread down 300 bps; term loan spread down 375 bps to 3%)
  • Cash: $451m at quarter end (up nearly $100m vs 2025)
  • Leverage: total leverage 2.7x; net leverage 2.1x; net leverage target below 2.0x by end of 2026
  • No material maturities until 2028; revolver undrawn as of March 31 with $180m available at April 29 closing

AI IconStrategy & Ops

  • Protocol positioning: end-to-end digitization of the four core actions (“what to measure/what to take/what to do/who to do it with”) with distributors as the engagement layer
  • Protocol beta: expanded to select 10 EMEA markets; next release planned for North America Extravaganza in July including new user experience and enhanced features
  • Packaging modernization rollout began in March; substantially completed by 2027
  • Extravaganza events: initial 2026 events started in India (three consecutive events in Delhi and Bengaluru; ~46k attendees); further summer events planned across China, Eurasia, South America, Asia Pacific, Europe, and North America

AI IconMarket Outlook

  • Q2 2026 reported net sales guidance: +1.5% to +5.5% YoY; ~50 bps currency tailwind; constant currency: +1% to +5% YoY
  • Q2 2026 adjusted EBITDA guidance: $150m–$170m (reported and constant currency); includes ~ $10m YoY headwind (~80 bps margin) from (1) timing of China government grant (~$5m) and (2) India GST services mismatch creating incremental G&A (~$5m, partially offset by reduced distributor sales commission percentage)
  • Full-year 2026 reported net sales guidance: +1.5% to +5.5% YoY; constant currency: +1% to +5% YoY; FX tailwind reduced to 50 bps from 100 bps vs prior guidance
  • Full-year 2026 adjusted EBITDA guidance: $675m–$705m (narrowed ranges; constant currency midpoint increased)
  • Full-year India GST-related net incremental cost: ~$20m–$25m headwind to adjusted EBITDA; ~40–50 bps headwind to adjusted EBITDA margin
  • 2026 CapEx: $50m–$80m; capitalized SaaS implementation costs: $35m–$55m (incremental to CapEx)

AI IconRisks & Headwinds

  • Adjusted EBITDA margin compression: down 20 bps YoY despite strong top-line, driven by FX (~70 bps), lower absorption rates, and unfavorable sales mix (~30 bps)
  • India momentum relies on GST tailwind; management expects tailwind through September 2026, then moderating
  • Regional softness: North America net sales down 3% YoY due to severe weather temporary club closures and shipment/revenue deferrals; China down 12% reported YoY driven by 18% volume decline
  • Higher 2026 effective tax rate: adjusted effective tax rate 27.3% in Q1 vs 21.8% in 2025; discrete-event benefit reduced vs prior year

Q&A: Analyst Interest

  • Topic: Protocol U.S. beta behavior and distributor/customer engagement signals: Management said beta’s purpose is distributor feedback and validating fit with distributor business flows, not direct forecasting. They paused/controlled beta phases while expanding to 10 EMEA markets; enhanced release is planned for Extravaganza July. They explicitly stated no direct revenue is included in forecasts yet.
  • Topic: India GST-driven demand and whether other markets will see price-reduction programs: Management began by framing “a lesson in India,” explaining GST created momentum via an effective price decrease. The transcript cuts off before providing the remaining guidance assumptions for India constant currency for the rest of 2026 and whether similar ~30% growth is expected.

Sentiment: MIXED

Note: This summary was synthesized by AI from the HLF Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Herbalife Nutrition Ltd. (HLF) Financial Profile